WallStreetZenWallStreetZen

NASDAQ: ZURA
Zura Bio Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ZURA

Based on 4 analysts offering 12 month price targets for Zura Bio Ltd

Min Forecast
$3.00+108.33%
Avg Forecast
$11.25+681.25%
Max Forecast
$17.00+1,080.56%

Should I buy or sell ZURA stock?

Based on 4 analysts offering ratings for Zura Bio Ltd.

Strong Buy
Strong Buy
2 analysts 50%
Buy
1 analysts 25%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ZURA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ZURA as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their ZURA stock forecasts and price targets.

ZURA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-09
lockedlocked$00.00+00.00%2025-04-03
lockedlocked$00.00+00.00%2025-03-26
lockedlocked$00.00+00.00%2025-03-26

1 of 1

Forecast return on equity

Is ZURA forecast to generate an efficient return?

Company
-49.7%
Industry
150.95%
Market
91.07%
ZURA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ZURA forecast to generate an efficient return on assets?

Company
-39.82%
Industry
47.18%
ZURA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ZURA earnings per share forecast

What is ZURA's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.71
Avg 2 year Forecast
-$0.77
Avg 3 year Forecast
-$0.96

ZURA revenue forecast

What is ZURA's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$94.3M
Avg 2 year Forecast
$206.5M

ZURA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ZURA$1.44$11.25+681.25%Strong Buy
GUTS$1.82$10.00+449.45%Strong Buy
ABOS$1.46$6.33+333.77%Strong Buy
XBIT$2.90N/AN/A
ONCY$1.04$4.33+316.63%Strong Buy
View Top Biotech Stocks

Zura Bio Stock Forecast FAQ

Is Zura Bio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: ZURA) stock is to Strong Buy ZURA stock.

Out of 4 analysts, 2 (50%) are recommending ZURA as a Strong Buy, 1 (25%) are recommending ZURA as a Buy, 1 (25%) are recommending ZURA as a Hold, 0 (0%) are recommending ZURA as a Sell, and 0 (0%) are recommending ZURA as a Strong Sell.

If you're new to stock investing, here's how to buy Zura Bio stock.

What is ZURA's earnings growth forecast for 2025-2027?

(NASDAQ: ZURA) Zura Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.59%.

Zura Bio's earnings in 2025 is -$62,098,000.On average, 6 Wall Street analysts forecast ZURA's earnings for 2025 to be -$43,931,249, with the lowest ZURA earnings forecast at -$51,356,248, and the highest ZURA earnings forecast at -$27,843,749. On average, 6 Wall Street analysts forecast ZURA's earnings for 2026 to be -$47,748,936, with the lowest ZURA earnings forecast at -$53,831,248, and the highest ZURA earnings forecast at -$38,981,249.

In 2027, ZURA is forecast to generate -$59,090,623 in earnings, with the lowest earnings forecast at -$60,018,748 and the highest earnings forecast at -$58,162,498.

What is ZURA's revenue growth forecast for 2030-2031?

(NASDAQ: ZURA) Zura Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 62.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.

Zura Bio's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast ZURA's revenue for 2030 to be $5,834,193,561, with the lowest ZURA revenue forecast at $5,834,193,561, and the highest ZURA revenue forecast at $5,834,193,561.

In 2031, ZURA is forecast to generate $12,774,712,087 in revenue, with the lowest revenue forecast at $12,774,712,087 and the highest revenue forecast at $12,774,712,087.

What is ZURA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ZURA) forecast ROA is -39.82%, which is lower than the forecast US Biotechnology industry average of 47.18%.

What is ZURA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ZURA price target, the average ZURA price target is $11.25, with the highest ZURA stock price forecast at $17.00 and the lowest ZURA stock price forecast at $3.00.

On average, Wall Street analysts predict that Zura Bio's share price could reach $11.25 by May 9, 2026. The average Zura Bio stock price prediction forecasts a potential upside of 681.25% from the current ZURA share price of $1.44.

What is ZURA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ZURA) Zura Bio's current Earnings Per Share (EPS) is -$0.70. On average, analysts forecast that ZURA's EPS will be -$0.71 for 2025, with the lowest EPS forecast at -$0.83, and the highest EPS forecast at -$0.45. On average, analysts forecast that ZURA's EPS will be -$0.77 for 2026, with the lowest EPS forecast at -$0.87, and the highest EPS forecast at -$0.63. In 2027, ZURA's EPS is forecast to hit -$0.96 (min: -$0.97, max: -$0.94).

What is ZURA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ZURA) forecast ROE is -49.7%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.